TELA Bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2017
Net Income	-46.66	-44.3	-33.28	-28.79	-30.21	Upgrade
Depreciation & Amortization	0.81	1.19	0.54	0.53	0.58	Upgrade
Share-Based Compensation	5.03	3.99	3.66	2.06	0.46	Upgrade
Other Operating Activities	-0.03	-1.63	-1.35	1.76	-4.14	Upgrade
Operating Cash Flow	-40.86	-40.75	-30.43	-24.46	-25.52	Upgrade
Capital Expenditures	-0.6	-0.87	-0.63	-0.17	-0.2	Upgrade
Change in Investments	0	0	0	9.29	-9.28	Upgrade
Other Investing Activities	-	-1	-	-	-2.5	Upgrade
Investing Cash Flow	-0.6	-1.87	-0.63	9.12	-11.98	Upgrade
Share Issuance / Repurchase	46.56	34.47	0.59	44.41	51.17	Upgrade
Debt Issued / Paid	0	6.54	0	0	0	Upgrade
Other Financing Activities	-0.29	-0.16	-	-	14.37	Upgrade
Financing Cash Flow	46.27	40.85	0.59	44.41	65.53	Upgrade
Exchange Rate Effect	0.16	-0.14	0.01	0.02	-0	Upgrade
Net Cash Flow	4.98	-1.91	-30.46	29.09	28.02	Upgrade
Free Cash Flow	-41.46	-41.62	-31.06	-24.62	-25.72	Upgrade
Free Cash Flow Margin	-70.92%	-100.49%	-105.42%	-135.19%	-166.52%	Upgrade
Free Cash Flow Per Share	-1.81	-2.56	-2.15	-1.90	-14.56	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).